Table 3. Linear regression models were used to find Pearson correlation coefficients and part correlations, with adjustments for age as a covariate, between anthropometric measurements of central adiposity and biomarkers of cardiometabolic disease.
Pearson correlation coefficients (r) | Part correlation coefficients, accounting for age | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Seated | Supine | Seated | Supine | |||||||||
AC (cm) | WC (cm) | AC (cm) | WC (cm) | HC (cm) | Waist:hip ratio | AC (cm) | WC (cm) | AC (cm) | WC (cm) | HC (cm) | Waist:hip ratio | |
Blood Pressure | ||||||||||||
SYS | 0.05 | 0.19 | 0.11 | 0.19 | 0.27 | -0.01 | 0.04 | 0.24 | 0.13 | 0.24 | 0.27 | -0.04 |
DIA | 0.10 | 0.23 | 0.09 | 0.25 | -0.07 | 0.44† | -0.12 | 0.08 | -0.11 | 0.09 | -0.15 | 0.37 |
Whole-body Physiology | ||||||||||||
VO2 peak | -0.05 | 0.15 | -0.40 | -0.44 | -0.22 | -0.39 | -0.05 | 0.15 | 0.06 | 0.06 | -0.05 | 0.16 |
BMR | -0.08 | 0.06 | -0.05 | -0.07 | 0.32 | -0.23 | 0.17 | 0.33 | 0.18 | 0.38 | 0.42† | -0.04 |
Lipid Profile | ||||||||||||
LDL-C | 0.35 | 0.42 | 0.33 | 0.33 | 0.48† | -0.03 | 0.55* | 0.61* | 0.50† | 0.54† | 0.51† | 0.02 |
HDL-C | -0.16 | -0.11 | -0.06 | -0.08 | 0.21 | -0.34 | 0.07 | 0.12 | 0.19 | 0.20 | 0.31 | -0.18 |
Non-HDL | 0.55* | 0.53† | 0.50† | 0.51† | 0.49† | 0.20 | 0.58* | 0.54† | 0.50† | 0.54† | 0.46† | 0.10 |
Total cholesterol | 0.48† | 0.47† | 0.46† | 0.47† | 0.53† | 0.10 | 0.58* | 0.55† | 0.53† | 0.57* | 0.52† | 0.04 |
TG+ | 0.51† | 0.34 | 0.44† | 0.45† | 0.09 | 0.53† | 0.19 | -0.09 | 0.11 | 0.10 | -0.07 | 0.22 |
FFA | 0.10 | 0.09 | 0.17 | 0.20 | -0.10 | 0.36 | 0.09 | 0.08 | 0.15 | 0.19 | -0.14 | 0.44 |
Carbohydrate Profile | ||||||||||||
HbA1c | 0.29 | 0.16 | 0.20 | 0.27 | -0.16 | 0.52† | -0.07 | -0.22 | -0.16 | -0.11 | 0.31 | 0.24 |
Si+ | -0.49† | -0.29 | -0.47† | -0.45† | -0.16 | -0.44 | -0.18 | 0.13 | -0.14 | -0.07 | 0.01 | -0.08 |
Sg+ | 0.11 | 0.09 | 0.14 | 0.07 | 0.35 | -0.24 | 0.31 | 0.27 | 0.33 | 0.26 | 0.41 | -0.20 |
Inflammatory markers | ||||||||||||
CRP+ | 0.18 | 0.09 | 0.10 | 0.10 | 0.02 | 0.13 | 0.13 | 0.01 | 0.17 | 0.21 | 0.05 | 0.21 |
TNF-α+ | 0.44† | 0.43 | 0.36 | 0.38 | 0.25 | 0.28 | 0.51† | 0.48† | 0.49† | 0.56* | 0.27 | 0.37 |
IL-6- | -0.02 | -0.05 | -0.05 | -0.09 | -0.03 | -0.08 | 0.04 | -0.01 | 0.09 | 0.06 | 0.03 | 0.05 |
Abdominal circumference; AC, basal metabolic rate; BMR, c-reactive protein; CRP, diastolic blood pressure; DIA, free fatty acid; FFA, glucose effectiveness; Sg, glycated hemoglobin; HbA1c, high-density lipoprotein cholesterol; HDL-C, hip circumference; HC, insulin sensitivity; Si, interleukin 6; IL-6, low density lipoprotein cholesterol; LDL-C, peak oxygen uptake; VO2 peak, systolic blood pressure; SYS, triglycerides; TG, tumor necrosis factor alpha; TNF-α, waist circumference; WC.
+ positive skew (data was log transformed prior to analysis)
- negative skew (data was reflected and log transformed prior to analysis).
†P < 0.05
* P < 0.01.